Revenue segments as reported by the company.

Personal Care

Consumer Tissue

K-C Professional

Corporate & Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, research and general expenses

Other (income) and expense, net

Impairment of intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Kimberly-Clark

Huggies is the brand name of a disposable diaper marketed by Kimberly-Clark.

Huggies

Is your child ready to transition from diapers to Big Kid underwear? Huggies Pull-Ups training pants help teach potty skills while providing reliable protection where kids need it most.

Pull-Ups

Kleenex is a brand name for a variety of paper-based products such as facial tissue, bathroom tissue, paper towels, tampons, and diapers. Often used informally as a genericized trademark for facial tissue in the United States, the name Kleenex is a registered trademark of Kimberly-Clark Worldwide, Inc. Kleenex products are manufactured in 30 countries and sold in more than 170 countries. Kleenex brands include Cottonelle, Huggies, and VIVA.

Kleenex

Scott Paper Comapny was the world's largest manufacturer and marketer of sanitary tissue products with operations in 22 countries. Its products were sold under a variety of well-known brand names, including Scott Tissue, Cottonelle, Baby Fresh, Scottex and Viva. Consolidated sales of its consumer and commercial products totalled approximately $3.6 billion in 1994. The company was acquired by the Kimberly-Clark Corporation in 1995.

Scott Paper Company

Depend has been helping people manage their bladder leakage for more than 35 years. But beyond making outstanding absorbent products, we’re also working to give our users the confidence to reconnect with the life they’ve been missing.

Depend

Kimberly-Clark Corp. engages in the manufacture and marketing of products made from natural or synthetic fibers. It operates through the following segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, training and youth pants, swim pants, baby wipes, feminine and incontinence care products, and other related products. The Consumer Tissue segment produces and sells facial and bathroom tissue, paper towels, napkins, and related products for household use. The K-C Professional segment supplies workplace supporting products such as wipers, tissue, towels, apparel, soaps, and sanitizers. The company was founded by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Frank C. Shattuck in 1872 and is headquartered in Irving, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Kimberly-Clark (KMB) reports robust sales growth and margin recovery

Kimberly-Clark's Q4 2022 earnings call highlights strong sales growth, margin recovery, and strategic investments in innovation and sustainability. While facing inflation challenges and softer market share performance, the company remains focused on driving long-term shareholder value through brand health and customer expectations.

Kimberly-Clark reports robust Q1 performance and plans for growth

Kimberly-Clark's Q1 earnings call highlighted strong performance, raised outlook, and strategies to address challenges. The company aims to drive sustainable growth, expand gross margins, and improve market share performance in key segments.

Kimberly-Clark excels in Q2 with strong growth and margin improvement

Kimberly-Clark delivered strong Q2 results with organic growth, margin improvement, and raised outlook for the year.
The company's focus on innovation, marketing efficiency, and proactive strategies position it well for future growth.
Challenges in market share and cost environment are being addressed through strategic adjustments and margin expansion initiatives.
Opportunities in expanding margins, innovation, and market expansion present avenues for sustained growth and performance.

Kimberly-Clark reports stellar Q3 results, eyes sustained growth ahead

Kimberly-Clark's Q3 performance showcased robust growth driven by strong segment results and new product initiatives.
While facing challenges related to costs and market dynamics, the company's strategic strengths position it well for future opportunities.
With an optimistic outlook for the full year, Kimberly-Clark remains focused on sustaining growth momentum and profitability.
Overall, the earnings call highlighted a solid performance, strategic strengths, challenges to address, and promising opportunities ahead.

Kimberly-Clark (KMB) posts strong 2023 performance, focuses on volume growth

Kimberly-Clark's CEO highlights volume growth plans amidst challenges, anticipates segment growth.

Kimberly-Clark excels in Q1 with strong growth and strategic focus

Kimberly-Clark's Q1 performance reflects strong volume growth, market share gains, and productivity initiatives. The company's focus on innovation and cost management strategies positions it well to navigate challenges from global uncertainties and input cost inflation. Strategic decisions to differentiate brands and exit private label businesses present opportunities for future growth.

Kimberly-Clark reports robust Q2 performance and strategic growth initiatives

Kimberly-Clark's Q2 2024 earnings call highlighted strong market share gains, strategic focus on growth, and cost-saving initiatives. While investments may impact margins, the company is well-positioned to capitalize on volume growth opportunities and drive efficiency through organizational changes.

Kimberly-Clark (KMB) progresses on growth strategy amidst market challenges

Kimberly-Clark (KMB) is navigating challenges like retail inventory reductions and shipment hurdles while focusing on sustainable growth through innovation and cost management.
The company's strategic shift towards science-based innovation and market share expansion positions it well for long-term success despite market headwinds.
Strong execution, disciplined profitability management, and flexibility in strategic decision-making are key drivers for Kimberly-Clark's growth and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Apple

Automatic Data Processing

Aflac

Baxter

Becton, Dickinson and Co.

Carrier Global

Caterpillar

Colgate-Palmolive

Clorox

ConocoPhillips

Chevron

Dominion Energy

Deere & Company

Emerson Electric

General Electric

General Mills

Genuine Parts

Hershey

Johnson & Johnson

Kraft Heinz

Kinder Morgan

Coca-Cola

Lockheed Martin

This real-money portfolio wrapped up its eighth year with its best income-growing showing ever. Thanks to a dividend raise and several special payouts, ConocoPhillips was one of the DG50's star performers.

Dividend Growth 50: Income In Year 8 Was Truly Great

Abbott Labs

Archer-Daniels-Midland Company

Amgen

Air Products and Chemicals

Apogee Enterprises

Broadcom

Booz Allen Hamilton Hld

Balchem

Franklin Resources

Blackrock Inc

Bristol-Myers

Church & Dwight

Cincinnati Financial

CubeSmart

California Water Service Group

Enterprise Bancorp

Ecolab

Con Ed

Eastman Chemical

Fastenal

Franklin Electric

Graco

Eli Lilly

Mastercard

There were several double-digit boosts in December, with Mastercard and Eli Lilly leading the way with 16% and 15% increases, respectively. Abbott Labs began its second half-century of dividend growth with an 8.5% increase.

BlackRock, Kimberly-Clark Among 13 Companies To Start 2023 With Annual Dividend Increases

ABM Industries

Black Hills

Federal Realty Investment Trust

Leggett & Platt

Lowe's

Altria

National Fuel Gas

Northwest Natural Gas

Parker-Hannifin

Stanley Black & Decker

Sysco

Target

Tennant

Universal Corp

"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years." - Dogs of the Dow. The 41 Dividend Kings and 2 Princes (next in line for kingship) (K&P) screened as of December 28, 2022, represented ten of eleven Morningstar Sectors. Broker targeted-top-ten net-gainers ranged 9.61%-20.75%.

January Dividend Kings And Princes: 3 Buys And 2 To Watch

AbbVie

A. O. Smith

Cardinal Health

Cintas Corp

Expeditors International of Washington

General Dynamics

W.W. Grainger

Hormel Foods

Illinois Tool Works

New Linde PLC

I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process and comparing the results to NOBL and SCHD.

Selecting Dividend Aristocrats Using SCHD's Methodology - Initial Results

Gilead Sciences

Viatris

These stocks all pay more than 3% in dividends.

3 High-Yielding Dividend Stocks That Could See Hikes in January

Five Below

Flowers Foods

Alphabet

As fears mount of a global economic slowdown, investors should start facing reality and consider acquiring recession-proof stocks to buy. Of course, no investment category offers 100% guarantees – otherwise, everyone would take them.

7 Recession-Proof Stocks to Buy as Market Fears Mount

News for Kimberly-Clark Stock (KMB)